Decreased interleukin 2 production and increased LEU 2a-positive suppressor cells in renal transplant patients on triple therapy with mizoribine, cyclosporine A, and prednisolone.
D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface / Q000032:analysis; D003208:Concanavalin A / Q000494:pharmacology; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000096:biosynthesis*; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D014181:Transplantation Immunology
D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D003524:Cyclosporins; D007376:Interleukin-2; D012263:Ribonucleosides; D003208:Concanavalin A; C010052:mizoribine; D011239:Prednisolone